Patent details

EP1776377 Title: NOVEL STEROID AGONIST FOR FXR

Basic Information

Publication number:
EP1776377
PCT Application Number:
PCT/EP/2005/002086
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057155962
PCT Publication Number:
WO/2005/082925
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL STEROID AGONIST FOR FXR
French Title of Invention:
NOUVEAU AGONIST STEROIDAL POUR FXR
German Title of Invention:
NEUER STEROIDAGONIST FÜR FXR
SPC Number:

Dates

Filing date:
28/02/2005
Grant date:
30/07/2008
EP Publication Date:
30/07/2008
PCT Publication Date:
09/09/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/04/2007
EP B1 Publication Date:
30/07/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/02/2022
Expiration date:
28/02/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/02/2005
 
 

Name:
Intercept Pharmaceuticals, Inc.
Address:
421 Hudson Street, Suite 212, New York, NY 10014, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
22/10/2008
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
PELLICCIARI Roberto
Address:
Italy (IT)

Priority

Priority Number:
04004408
Priority Date:
26/02/2004
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07J 9/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
25/02/2021
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
Computer Packages INC
Filing date Document type Number of pages